Purpose. This study was performed to demonstrate that the results obtained with a calibration phantom could be used as a tool for standardizing measurement of heart-tomediastinum (H/M) ratio in cardiac metaiodobenzylguanidine (MIBG) imaging.Method. Images of the phantom containing 123 I-MIBG were acquired on the cameras in 10 hospitals (11 camera types) to determine the relationship between H/M ratios using different collimators: low energy (LE) and medium-energy (ME)/low-medium-energy (LME) collimators. The effect of standardization to the ME-comparable H/M ratio was examined in two settings: a Japanese standard MIBG database (n=62) and multi-center studies (n=49). In a multi-center study, probable Alzheimer disease (AD, n=18) and probable dementia with Lewy bodies (DLB, n=31) were studied and standardized by the calibration phantom method.Results. Linear regression equations between LE and ME collimators were obtained for the phantom study in all institutions. When the H/M ratio with a LE collimator was corrected based upon the calibration phantom, the corrected values were comparable to those obtained using ME collimators. The standard database also exhibited a normal distribution after standardization as determined by skewness and goodness-of-fit test. A mixture of the 2 populations by LE and ME collimators showed significant separation of AD and DLB groups (F ratio=24.9 for the late H/M), but the corrected values resulted in higher F ratios for both early and late H/M (F ratio= 34.9 for the late H/M).
Conclusion.Standardization of H/M ratios by the heart-chest calibration phantom method is feasible among different collimator types. This method could be practically used for multicenter comparison of H/M ratios.Key Words: 123 I-metaiodobenzylguanidine; heart-to-mediastinum ratio; calibration phantom; Lewy-body disease; standardization
Introduction123 I-metaiodobenzylguanidine (MIBG) has been used extensively in fields of cardiology and neurology as a unique imaging method to evaluate sympathetic nerve activity and its integrity [1][2][3][4][5][6][7]. Inter-institutional differences in MIBG quantification using the heart-tomediastinum ratio (H/M) have hampered multi-center comparison of the H/M ratio, and single-center results could not easily be extrapolated to other hospitals [8]. Since the difference in collimator type has been investigated and found to be one of the major confounders of the results, a practical standardization method for quantification has been sought [9][10][11][12].In neurological studies, patients with Parkinson disease and dementia with Lewy bodies (DLB), which is categorized as Lewy-body disease demonstrated significantly lower H/ M ratios both in early and late imaging [4][5][6][7]. Since the patients with Lewy-body disease showed lower H/M values compared with those of normal populations, we used this patient group for a pilot study of the procedure for correction of H/M ratios. In addition, since a multi-center study including DLB and MIBG imaging has started in Japan, an a...